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ABSTRACT
Purpose: To evaluate the influence of PRP addition on bone repair of circular defects created in irradiated tibiae of rats by histometric
analysis. Methods: Sixty male Wistar rats had the right tibiae irradiated with 30 Gy. After 30 days monocortical defects were created and
platelet-rich plasma was applied in 30 rats. In the control group defects were created but not filled. The animals were desanguinated after
4, 7, 14, 21, 56 and 84 days and the tibiae removed for histological processing. Results: There was a tendency in the PRP group to
increased bone neoformation from 14-days to 84-days; in the control group increased bone neoformation was not seen after 21 days or
later. Conclusion: The addition of platelet-rich plasma had a beneficial effect in the initial cellular regeneration period and enhanced
bone formation in later periods when compared to control.
Key words: Platelet-Rich Plasma. Radiation Injuries, Experimental. Bone Regeneration.
RESUMO
Objetivo: Avaliar histometricamente a influência do PRP na reparação óssea de defeitos circulares criados em tíbia irradiada de ratos
Wistar. Métodos: Sessenta ratos machos tiveram a tíbia direita irradiada com 30Gy. Após 30 dias, defeitos ósseos monocorticais foram
criados e PRP foi adicionado em 30 ratos. No grupo controle os defeitos foram criados, mas não preenchidos. Os animais foram sacrificados
em 4, 7, 14, 21, 56 e 84 dias e a tíbia removida para processamento histológico. Resultados: Houve uma tendência do grupo PRP mostrar
uma neoformação óssea significativamente maior nos períodos de 14 a 84 dias; no grupo controle o aumento da reparação óssea não se
manteve após 21 dias. Conclusão: A adição de PRP mostrou-se benéfica no período inicial de reparação celular e em períodos seqüentes
foi estímulo à quantidade neoformação óssea, quando comparado ao controle.
Descritores: Plasma Rico em Plaquetas. Lesões Experimentais por Radiação. Regeneração Óssea.
1Research performed at the Department of Otorhinolaringology and Head and Neck Surgery, Federal University of São Paulo (UNIFESP), Brazil.
Introduction
Resection of malignant tumors, especially in the head and
neck region, necessities reconstruction to give back to patient the
possibility to speak, swallow, and maintenance of the respiratory
pathways, and facial aesthetics. However, the results might be
limited due to the damages inflicted on the tissues by the
radiotherapy. The lower jaw is one of the bones more frequently
affected by the radiation and complications can be seen years after
the radiation, varying from the simple bone exposure to extensive
bone necrosis accompanied by severe pain. The incidence of
mandibular osteoradionecrosis in patients with cancer of head and
neck vary in the literature from 0,4% to 56%, and though it
typically takes place in the first three years after the radiotherapy,
patients present a constant risk later on1-3. The irradiated bone is
characterized by the absence of osteoclasts which induces delay in
bone resorption; micro-fractures containing fibrous tissue but
without formation of callus can further be seen; and three times
more incomplete osteons are observed and intra-bone ischemia,
multiple emboli, extensive tissue hypoxia and cellular secondary
destruction has been observed1.
The use of platelet rich plasma in bone regeneration
was first used in order to aggregate particulate autogenous bone
in mandibular reconstruction. From that time, the potential
proliferative effect of platelet rich plasma (PRP) has been explored
in craniofacial reconstruction, especially in oral rehabilitation with
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dental implants, and with several graft materials.
Platelet rich plasma used in maxillofacial surgery seems
to increase the speed of regeneration when mixed with bone grafts.
The blood platelets, cytoplasmic fragments of megakaryocytes,
secrete proteins that begin tissue regeneration, such as platelet-
derived growth factor (PGDF), transforming growth factor alpha
(TGF-alfa) and beta (TGF-beta), epidermal growth (EGF) and vascular
endothelial growth factor (VEGF)4. In the plasma the mean normal
concentration of platelet is 150,000 to 400,000/mm3 of blood and,
after centrifugation, it can be increased in up to 338 %5.
In the search of ideal therapies with growth factors that
could provide improvement of the regenerative process of bone
tissue affected by radiation, it seems valuable to study the
applicability of the PRP, a material with osteoinductive, osteogenic
and osteoconductive properties, from easy accomplishment and
availability, immunologically inert and economically accessible.
Purpose
The aim of this experimental study was to evaluate the
effect of platelet rich plasma in the bone regeneration of bone
defects created in rat tibiae previously radiated with doses of
30Gy, and further to establish a comparative analysis with a
radiated control group.
Methods
This experiment was approved by the ethics committee of
UNIFESP - Federal University of Sao Paulo and followed the
CIOMS (Council for International Organization of Medical
Sciences) ethical code for animal experimentation.
Sixty (60) male Wistar rats, between 90 and 120 days of
age and average weight of 450g constituted the sample of this
study. cycle). They had ad libitum access to acidified drinking
water (pH = 2,8-3,1) and a standard laboratory rat food pellet
diet (20g/day). The animals were maintained in sterile individual
polycarbonate cages.
Anesthesia
General anesthesia was induced, for both radiation and
surgical procedures, by intraperitoneal injection of xilasin 2%
(0,1ml/kg) and ketamine 10% (1ml/kg).
Radiation procedure
The radiation of the animals followed the protocol of
Ohrnell et al.6. In rat, the application of 30Gy caused a significant
reduction of the bone regeneration capacity but acute effects
that were well supported by the animal. When a single dose of
30Gy was compared to clinical practice it would correspond to
approximately 50-70Gy applied in fractioned radiotherapy6.
The radiation procedure was carried out 30 days before
the surgery. After anesthesia, 10 to 14 animals were simultaneously
immobilized in a transparent acrylic plate. The right tibiae were
put in a field of 20 X 20 cm size and 80cm source-skin distance
and immobilized with a plastic fastener. The left paws and tails
were fixed and put out of the field of radiation.
Before radiation, the animals were subjected to a digital
simulator of radiation, to guarantee a homogeneous dose of
radiation. In the sequence, the animals were irradiated with a
single dose of 30Gy in a Cobalt 60 equipment.
PRP preparation
Two animals, anaesthetized and irradiated at same time of
the of the experimental animals group, were sacrificed to get PRP
sufficient for ten surgical procedures. An aorta heart puncture with
complete exsanguination was performed using a 10ml sterile
disposable syringe. Approximately 20ml of blood was collected
and immediately transferred to sterile tubes with 0.5ml of 3.2%
sodium citrate.
The blood was first centrifuged at 200G for 10min to
separate plasma from red cells. With a disposable syringe, the
whole portion of plasma in the superior part of the tube was drawn
off and transferred to “dry” tubes. The second centrifugation,
carried out at 200G during 15min, separated platelets in poor,
average and rich phases. The two superior thirds of the platelet
poor plasma were collected and dispensed. The inferior third,
platelet rich plasma, was transferred to a sterile Petri plate. The
quantity of PRP obtained was approximately 10 to 15% of the total
volume of blood. The activator 10% calcium chloride was added
in a ratio of 1:20 for total volume of PRP.
Platelet counts were performed to calculate the PRP
concentrate, which should be around 400% of the peripheral
blood platelet count or at least a concentration of 1.000.000
platelet/microliter in a volume of 5ml.
Surgical procedure
The animals were separated in two groups of 30 animals.
The experimental group received the PRP graft in the bone defect
in the tibiae, while in the control group was carried out only the
bone defect.
The surgical procedures were performed 30 days after
the radiation, given that the acute local side effects (epithelial
desquamation, erythema and loss of hair) and systemic symptoms
(illness and fatigue) after a dose of 30Gy were reverted in the first
three weeks6 and the interval of time between the radiation and the
surgery does not influence the bone regeneration7.
Both right and left sides were operated to assure similar
morbidity and so to reduce the possibility of the animal to use more
the non irradiated side (left) in detriment of the experimental
irradiated side (right).
The animals were anaesthetized, and both legs were shaved
and washed with iodine-povidine. The operation was effectuated
in sterile environment and with a gentle surgical technique. A
longitudinal linear incision of approximately 2cm in the medial
region of the tibiae was made to expose the subcutaneous tissue
and the musculature. The periosteum was exposed and incised,
exposing the bone tissue of the medial portion of the tibiae
metaphysis.
The circular monocortical defects of 3mm of diameter were
created with trephine burs (FTR02 - Sin, Brazil) under profuse and
constant irrigation with saline sterile solution to avoid thermal
damage to the tissues (Figure 1).
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In the experimental group, the resultant bone defect was
filled up to superior cortical limit by PRP, while in the control group
there were no grafts.
The wound was closed in layers; the periosteum and
muscular tissue were sutured with resorbable suture (Vicryl rapide
4-0) and the skin was sutured with nylon 4-0 suture.
A dose of 16.000UI of antibiotic benzatil-penicillin was
given by intramuscular injection after surgery; paracetamol in the
dose of 500mg/500ml of water to drink was administered to the
animals in the first two post-operative days.
Histological examination
In the periods previously established at 4, 7, 14, 21, 56
and 84 days after surgery, subgroups of five animals each were
sacrificed by an overdose of anesthetic.
Skin around bone was carefully removed and the tibiae
were cut off with a bone saw. The pieces obtained were
conditioned in labeled containers with 10% formaldehyde solution
for at least 72 hours. After fixation the muscular tissues were
removed and the circular defects with a 3mm margin of
surrounding bone were sawn transversely. The specimens were
decalcified in a 10% EDTA solution during 24 to 36 hours, and
then washed in running water for 24 hours. Dehydration was
prosecuted in successive passages in alcoholic and xylol solutions
in automatic equipment. Specimens were then embedded in
paraffin, cut in 3 to 7 um thickness cross sections and stained
with hematoxyline-eosin and Masson trichrome stain.
Sections were examined in a light microscope, connected
to a camera and microcomputer Pentium 233Mhz equipped with
IMAGE-PRO ® PLUS - Version 3.0 software for morphometrical
measurements. The images were manipulated in Adobe Photoshop
6.0 with magic wand and rubber tools to delimit only the bone
tissue. The bone neoformation area was measured in micrometers
using Image J 1.38x software.
FIGURE 1 - Bone defect
 
Statistical methods
The statistical proceedings were carried out with
Statistical Package Social Sciences (SPSS) version 11.0 Windows.
ANOVA and Tukey were used for all comparisons between groups
and periods. The level of significance alfa was set at 5%.
Results
Table 1 and Figure 2 show the measured bone
neoformation area for control group (CTR) and experimental
group (PRP) according to the time period. It is possible to notice
that the bone area in CTR group seems to increase up to 21 days,
but decreased in the subsequent periods. In PRP group the
neoformation was progressively increasing during a period of
14 days and stabilized after 21 days. The variability of the data in
the group CTR also seems bigger than in the group PRP.
The results of the comparisons (ANOVA) between the
CTR and PRP groups in each period revealed statistically
significant differences. The PRP group presented significantly
bigger bone neoformation than the control group in all the periods,
except to 7 days. Since the measures in the 4 days period presented
null variability, the groups were not compared between them.
Period Group Mean SD ANOVA p-value 
4 CTR 0,0 0,0 — — 
 PRP 0,0 0,0   
7 CTR 4977,1 14931,3 CTR = PRP 0,247 
 PRP 22781,3 40638,8   
14 CTR 21225,4 24018,1 CTR < PRP <0,001 
 PRP 232909,8 51281,3   
21 CTR 126942,2 101958,4 CTR < PRP 0,012 
 PRP 237267,9 28240,4   
56 CTR 53892,6 90457,2 CTR < PRP <0,001 
 PRP 238381,6 40296,6   
84 CTR 121003,8 111498,7 CTR < PRP 0,005 
 PRP 264054,9 31758,2   
TABLE 1 – Mean and standard deviation for bone neoformation area.
Comparison between CTR and PRP groups for each period
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The comparisons between the periods for CTR and PRP
groups are respectively presented in Table 2. In CTR group only
the bone neoformation of the period of 21 days was superior to that
of the period of 7 days. So the result of the comparisons suggests
that the CTR group did not show significant bone neoformation
during the 84 days of experiment.
In the PRP group, however, all the periods after 14 days
were superior to the period of 7 days. Nevertheless, after 14 days
the quantity of bone was not different between the periods,
suggesting that the effect of the PRP is more present in the first
14 days.
Figure 3 to 8 show histological results for for CTR and
PRP groups in each experimental period.
Period (days)
8456211474
Bone Area
(µm) 
400000
300000
200000
100000
0
-100000
Group
CTR
PRP
FIGURE 2 – Boxplot. Comparison between CTR and PRP groups
for each period
Compared periods CTR PRP
7 14 7 = 14 (p=0,453) 7 < 14 (p<0,001) 
7 21 7 < 21 (p=0,042) 7 < 21 (p<0,001) 
7 56 7 = 56 (p=0,534) 7 < 56 (p<0,001) 
7 84 7 = 84 (p=0,079) 7 < 84 (p<0,001) 
    
14 21 14 = 21 (p=0,082) 14 = 21 (p=0,999) 
14 56 14 = 56 (p=0,828) 14 = 56 (p=0,999) 
14 84 14 = 84 (p=0,148) 14 = 84 (p=0,551) 
    
21 56 21 = 56 (p=0,514) 21 = 56 (p>0,999) 
21 84 21 = 84 (p>0,999) 21 = 84 (p=0,361) 
    
56 84 56 = 84 (p=0,635) 56 = 84 (p=0,577) 
TABLE 2 - Comparison between the periods for CTR and PRP groups
  
FIGURE 7 – Control x PRP. Period of 56 days (100x)
FIGURE 3 – Control x PRP. Period of 4 days (100x)
FIGURE 4 – Control x PRP. Period of 7 days (100x)
FIGURE 5 – Control x PRP. Period of 14 days (100x)
FIGURE 6 – Control x PRP. Period of 21 days (100x)
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Discussion
Radiotherapy represents an established therapeutic
resource for the treatment of the head and neck cancer.
Approximately half of the patients with cancer use radiotherapy
in some phase of the treatment of the disease, isolated or
associated to other forms of therapy. However, its action is not
limited to the tumoral cells, in other words, normal tissues like the
epithelium, the mucous membrane, the glandular tissue and the
bone which are in the radiated field are also affected by radiation.
The effects of the radiotherapy in bone were first noticed
in 1922. The radiation has combined effects on the cellularity and
vascularization of the bone, with reduction of the number of cells
in the bone marrow, straightening of the vascular lumen, besides
the increase of empty gaps in the cortical bone1,3,8. Soon after the
radiation, the osteoblastic activity is abolished, but the osteoclastic
activity keeps on and can eventually increase for a short period of
time. This imbalance alters the process of bone remodeling,
represented for incomplete osteons in a proportion three times
bigger than the normal, and result in the increase of the porosity of
the bone1,8. There are still structural changes in the inorganic bone
content and alteration in the organic content of the bone matrix,
mostly in the type I collagen9. The endothelial cells are also
affected and the vascular fibrosis reduces the vascularization,
affecting the vitality of bone and marrow cells, and making the
area sensitive to infection and necrosis10. These effects can be
noticed soon after the radiation, but the risk of late side effects is
constant2. So, subsequent attempts of bone regeneration are
variable and below normal.
The effects are radiation dose dependent, and the damage
observed in the bone cells can persist for several weeks after a
single application. The tissue injuries also depend on the size and
volume of the radiated field, on the number and interval between
sessions, on the fragmentation of the dose, on the type of radiation
and on the surgical or traumatic damage to the radiated tissue. For
establishment of the necessary dose in the radiotherapy, the
tumoral mass must be considered. Microscopic tumors usually
apply for doses between 50 and 55Gy, while doses between 60
and 70 Gy are employed in larger tumors or in advanced stages of
the disease with high risk of local or regional recurrence11. In the
bone tissue the chance of recuperation of the structure reduces
considerably when the doses are greater than 60Gy, increasing
osteoradionecrosis incidence; severe cases generally are
associated to doses bigger than 70Gy3,8.
In animal model, Ohrnell et al.6 also found that the
capacity of bone regeneration was proportionally reduced with
larger doses of radiation up to the limit of 30Gy. Aitasalo8 observed
in the bone marrow of tibiae of rabbit that a dose so small as 5Gy
can provoke vascular alterations the next day of the application;
the destruction of osteoblasts was taking place one day after
radiation with 10Gy and of the osteoclasts with 20Gy; with a dose
of 30Gy, there can be persistence of edema and fibrosis. In the rat
femur bone defects of 1,2 mm of diameter, Arnold et al.7 noticed
that a dose of 13Gy caused damage of the bone regeneration by
reducing the cellular population below a critical level, while doses
greater than 15Gy provoked destruction of the clot and inhibition
of the regeneration process by affecting the cellular migration of
regions more distant of the bone marrow.
The pathogenesis of alterations in bone tissue is related to
the generation of free radicals by radiation and to the consequent
damage to the endothelial cells in the field of radiation. The
cellular death and the irreparable damages to the cells can cause a
chronic inflammation and progressive endothelial obliteration,
which results in ischemia and fibrosis in the tumoral tissue as well
as in the healthy tissues. The larger effects are seen in the DNA,
at the moment of major activity of the cycle of cellular division;
so tissues with bigger taxes of proliferation are most affected by
the radiation7,11. So the cumulative effect of the radiation conducts
to hypovascularization of the region, tissue hypoxia, destruction
of the cells of the bone tissue and fibrosis of the bone marrow10.
At biochemical levels it is possible that
hypovascularization, hypoxia and hypocellularity caused by the
radiation can in part be attributed to the reduction of growth
factors implicated in the tissue regeneration, like the PGDF and
TGF-beta12. So, the use of the PRP may allow the enlargement of
the concentrations of PDGF and TGF-beta, in the intention of
increase the rate and quantity of bone neoformation. The growth
factors are released from degranulation of the platelets, due to the
contact with the collagen exposed in the wound. The principal
growth factor released by the platelet granules, the PDGF reaches
the cells target, binding to the receptors of the membrane and
establishes connections of a tyrosin-kinase protein. It stimulates
the mitogenesis of osteoblasts and of steam-cells in the bone
marrow, the angiogenesis that guarantees the nutrition and the
local oxygenation, the activation of macrophages, besides
promoting perivascular migration of cells and modulating the
effects of other growth factors. The TGF-beta is a family of
local mediators and its principal activities are chemotaxia and
mitogenesis of the osteoblasts precursors, the maturing of the
osteoblasts, besides stimulating the deposition of collagen
matrix. When TGF-beta influence the osteoclasts it inhibit bone
resorption. Also they activate fibroblasts, endothelial cells,
osteoprogenitor cells, condroprogenitor cells and mesenchymal
cells.
The fact that PRP is an antilogous preparation introduced
at the moment of the surgery also reduces the risk for transmission
of diseases or immunological reactions which are associated to other
materials of allogenic or xenogenic origin; besides it constitutes a
material of easy attainment, low cost and simple clinical application5.
Earlier studies have already demonstrated that cells are
able to respond to the growth factors contained in the PRP5 but
more investigations are still necessary to determine the ideal
concentration of the different growth factors, but the advantages of
the application of the PRP in bone regeneration are undeniable.
The PRP has great mitogenic effect, but its action in bone
FIGURE 8 – Control x PRP. Period of 84 days (100x)
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regeneration is variable and dependent of the concentration,
which was demonstrated in experimental studies13.
In the models of bone regeneration without the influence
of radiation, it seems that PRP promoted an increase of the number
of osteoblasts in the initial periods of regeneration, and bone
increased density of 15% to 30%4. In bone defects filled with
autogenous bone or another osteoconductive material, the results
with PRP also showed greater bone neoformation in the initial
period14. Promising results were also obtained in studies
undertaken to increase of the alveolar ridge15. In studies of
maxilo-mandibular reconstruction with plates, autogenous bone
and PRP, the result can be more obvious after a longer period of
time16.
The use of the PRP in this study aimed to accelerate the
regenerative process of tissues promoting the primary stabilization
and the revascularization of the bone tissue. The results found in this
study suggest that the PRP had a positive effect in the regeneration
of irradiated bones. The analysis of Table 1 reveals that in the control
group the 21 days bone area was only superior to the 7 days period,
which suggests a later and limited answer of the bone filled out
only with the blood clot. This observation is in agreement with the
results of Fennis et al.17 in which the bone tissue irradiated with
high doses became not viable for clinical purposes.
On the other side, the PRP group demonstrated a quicker
and prolonged bone neoformation answer, in 14 days. The
observation is ratified by the observation of Table 1, in which
PRP group presented bigger bone neoformation than the control
group in all periods after 7 days. Besides, mean values of bone
area of the control group and PRP group are quite different. PRP
group presents values on average twice superior to the control
group, and in some cases up to ten times greater, as in the period of
14 days. Similarly, Aghaloo et al.12 observed an increase in the
expression of growth factors in 1 and 2 months after the graft of
autogenous bone with PRP. The findings of this investigation also
corroborate Cenni’s et al.18 affirmations that the bone regeneration
might be favored by a better vascularization, due to the effect of
PRP in the proliferation of the endothelial cells, and from Fréchette
et al.13, for whom it is clear that the stimulation of the formation of
blood vessels increases the osteogenic activity because the
angiogenesis precedes the osteogenesis and the osteblasts are
perivascular cells.
The absence of differences in the first 7 days of the study
does not mean that the PRP was not acting. The presence of greater
bone formation after 14 days suggests that in the first days the
PRP should have contributed to the formation of collagen matrix
which was later mineralized and quantified in this work. Under
this vision, the PRP had an effect proliferative in osteoblasts. So,
the absence of difference between the groups in the initial period
can be attributed to the imposed method of quantification of
bone tissue in the analyzed specimens, in other words, visual
identification of mineralized tissue.
In this study the PRP accelerated the bone neoformation,
showing advantages in its application for the rehabilitation
treatment of the irradiated bone. At the microscopic level, the PRP
allowed that the hypovascularization, hypoxia and hypocellularity
caused by the radiation were reduced by adding to the surgical bed
the necessary growth factors for the tissue regeneration, the
PGDF and TGF-beta. In clinical terms, the PRP can contribute to a
regeneration of the irradiated bone of better quality, supplying
growth factors that might increase the vascularization of the bone
and reduce the risks of osteoradionecrosis.
Conclusion
The addition of platelet-rich plasma had benefic effect
in initial cellular regeneration periods and enhanced the bone
formation in later periods when compared to control.
.
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